Phase II Study of KHK6188 (A Placebo-controlled, Double Blind, Crossover Study of KHK6188 in Postherpetic Neuralgia)
Latest Information Update: 11 Jul 2019
Price :
$35 *
At a glance
- Drugs KHK 6188 (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2013 Planned End Date changed from 1 Mar 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 21 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.